Efficacy and Safety of SBRT Combined With Atezolizumab Plus Bevacizumab vs Atezolizumab Plus Bevacizumab in Treating Unresectable Advance Hepatocellular Carcinoma.
Clinical trial NCT06244446 · UNKNOWN
Trial details
- NCT number
- NCT06244446
- Sponsor
- Institute of Liver and Biliary Sciences, India
- Status
- UNKNOWN
- Study type
- OBSERVATIONAL
- Start date
- 2024-02-05
- Primary completion
- 2025-01-31
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.